ストックスクリーナーアプリを入手
6.22
5.07%
0.30
前日終値:
$5.92
開ける：
$6.04
24時間の取引高:
410.49K
Relative Volume:
1.47
時価総額：
$171.26M
収益：
$61.86M
当期純損益:
$-11.43M
株価収益率:
-12.91
EPS:
-0.4818
ネットキャッシュフロー:
$-12.52M
1週間 パフォーマンス:
-0.80%
1か月 パフォーマンス:
-0.48%
6か月 パフォーマンス:
-21.46%
1年 パフォーマンス:
-2.05%
1日の値動き範囲:
$5.83
$6.25
1週間の範囲:
$5.83
$6.46
52週間の値動き範囲:
$4.31
$9.555
Journey Medical Corp Stock (DERM) Company Profile
名前
Journey Medical Corp
セクター
電話
480-434-6670
住所
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, HLN, TEVA, ZTS, UTHR
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
6.22 | 171.26M | 61.86M | -11.43M | -12.52M | -0.4818 |
TAK
Takeda Pharmaceutical Co Adr
|
15.63 | 49.39B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
8.96 | 39.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.48 | 36.66B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
78.71 | 33.00B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
536.59 | 22.78B | 3.17B | 1.29B | 1.01B | 27.09 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-25 | 開始されました | H.C. Wainwright | Buy |
| 2025-07-30 | 再開されました | B. Riley Securities | Buy |
| 2024-08-22 | 開始されました | Rodman & Renshaw | Buy |
| 2024-06-28 | 再開されました | ROTH MKM | Buy |
| 2021-12-07 | 開始されました | B. Riley Securities | Buy |
Journey Medical Corp (DERM) 最新ニュース
Journey Medical Corp (DERM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Journey Medical Corp (DERM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Journey Medical Corp (DERM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Journey Medical Corp (DERM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Journey Medical Corp (DERM) Institutional Confidence - TradingKey
Journey Medical Corp (DERM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Journey Medical Corp (DERM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Journey Medical Corp (DERM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
DERM Stock Price, Quote & Chart - ChartMill
Este Medical Group Announces Enhanced Consultation and Aftercare Pathway for International Hair Transplant Patients - Digital Journal
How The Journey Medical (DERM) Investment Narrative Is Evolving With An Unchanged Valuation Target - Yahoo Finance
Journey Medical Shares Drop—DERM’s 2026 Outlook Hinges on Emrosi Trial - Bez Kabli
10 Best Travel Insurance Companies For 2026 - Forbes
Journey Medical Corp stock (US48113J1007): calm start to the week after recent gains - AD HOC NEWS
Medical AI Market Size & Share | Industry Report, 2026-2033 - Grand View Research
Earnings call transcript: Journey Medical Q1 2026 shows 21% revenue rise - Investing.com
Journey Medical Analyst Ratings and Price Targets | NASDAQ:DERM - Benzinga
Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Iridex (IRIX) - The Globe and Mail
Best travel insurance if you have a medical condition 2026 - which.co.uk
Journey Medical CEO to join A.G.P. Virtual Healthcare Conference fireside chat on May 20, 2026 - Pluang
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference - The Manila Times
Journey Medical CEO to join online talk at A.G.P. health event - Stock Titan
Journey Medical Corp stock (US48113J1007): dermatology player in focus after recent financing update - AD HOC NEWS
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceuticals (SPRY) - The Globe and Mail
Journey Medical Corporation (NASDAQ:DERM) Q1 2026 Earnings Call Transcript - Insider Monkey
Lake Street Sticks to Its Buy Rating for Journey Medical Corp (DERM) - The Globe and Mail
Journey Medical Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Analyst Reiterates Buy on Journey Medical, Maintains $13 Price Target After Strong 1Q26 and Emrosi Momentum - TipRanks
Journey Medical Corp stock (US48113J1007): Q1 revenue jumps 21% to $16M - AD HOC NEWS
Journey Medical Corp (DERM) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Here's What Key Metrics Tell Us About Journey Medical (DERM) Q1 Earnings - Yahoo Finance
Earnings call transcript: Journey Medical Q1 2026 reports strong EPS beat - Investing.com
Journey Medical Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Earnings call transcript: Journey Medical Q1 2026 shows strong revenue growth - Investing.com
Transcript: Journey Medical Q1 2026 Earnings Conference Call - Benzinga
Journey Medical Corporation (DERM) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Journey Medical earnings beat by $0.05, revenue fell short of estimates - Investing.com
Journey Medical Corp (NASDAQ:DERM) Slightly Misses Q1 2026 Revenue Expectations as Stock Rises on Strong Emrosi Growth and Full-Year Profitability Outlook - ChartMill
Journey Medical (NASDAQ: DERM) grows Q1 2026 revenue 21% but remains unprofitable - Stock Titan
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times
Journey Medical (Nasdaq: DERM) posts 21% Q1 2026 revenue growth - Stock Titan
Rosacea pill Emrosi powers Journey Medical’s 21% Q1 revenue jump - Stock Titan
Assertio (ASRT) moves 17.0% higher: Will this strength last? - MSN
TradingKey - TradingKey
Journey Medical Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FS KKR Capital Corp. of Class Action Lawsuit and Upcoming DeadlinesFSK - PR Newswire
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 - GlobeNewswire
Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
AIROS Medical Introduces ARTAIRA Travel Case to Support Therapy Continuity for PAD Patients - PR Newswire
Journey Medical (DERM) Expected to Announce Earnings on Wednesday - MarketBeat
Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last? - Yahoo Finance
Journey Medical Corp (DERM) 財務データ
収益
当期純利益
現金流量
EPS
11.23%
0.45%
大文字化:
|
ボリューム (24 時間):